osteoarthritis rheumatoid arthritis and gouty arthritis

🔥+ osteoarthritis rheumatoid arthritis and gouty arthritis 02 Jul 2020 C-reactive protein is a marker of inflammation and may be more closely linked with tissue inflammation in symptomatic RA than the anti-CCP and other ...

osteoarthritis rheumatoid arthritis and gouty arthritis Rheumatoid Arthritis Research has Seen Major Advancements that Benefit Patients. Rheumatology as a subspecialty has come a long way ...


Your source for the latest research news
osteoarthritis rheumatoid arthritis and gouty arthritishow to osteoarthritis rheumatoid arthritis and gouty arthritis for New:
Science News
from research organizations

Date:
May 6, 2009
Source:
Wiley-Blackwell
Summary:
Spondylarthritis represents a group of arthritidies that share clinical features such as inflammatory back pain and inflammation at sites where tendons attach to bone.
Share:
FULL STORY

Spondylarthritis (SpA) represents a group of arthritidies that share clinical features such as inflammatory back pain and inflammation at sites where tendons attach to bone. It includes ankylosing spondylitis (AS), psoriatic arthritis, inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and undifferentiated spondylarthritides (uSpA).

advertisement

Since Chlamydia trachomatis or Chlamydia pneumoniae (which are often asymptomatic) frequently cause ReA, a new study examined whether there was a connection between these two infections and uSpA. 

Led by John D. Carter of theUniversity of South Florida, the study involved blood and synovial tissue analysis from 26 patients who had chronic uSpA or Chlamydia-induced ReA. Synovial tissue samples from 167 osteoarthritis patients were used as controls. Samples were analyzed to assess chlamydial DNA and the 26 subjects were asked if they had any known exposure to Chlamydia for 1 last update 2020/07/02 trachomatis or Chlamydia pneumoniae and if so, the infection was documented in relation to the onset of their uSpA. They also underwent a physical exam that included evaluation of swollen and tender joints and other symptoms of SpA. The results showed that the rate of Chlamydia infection was 62 percent in uSpA patients, significantly higher than the 12 percent seen in control subjects.Led by John D. Carter of theUniversity of South Florida, the study involved blood and synovial tissue analysis from 26 patients who had chronic uSpA or Chlamydia-induced ReA. Synovial tissue samples from 167 osteoarthritis patients were used as controls. Samples were analyzed to assess chlamydial DNA and the 26 subjects were asked if they had any known exposure to Chlamydia trachomatis or Chlamydia pneumoniae and if so, the infection was documented in relation to the onset of their uSpA. They also underwent a physical exam that included evaluation of swollen and tender joints and other symptoms of SpA. The results showed that the rate of Chlamydia infection was 62 percent in uSpA patients, significantly higher than the 12 percent seen in control subjects.

It is believed that as many as 150,000 cases of Chlamydia trachomatis-induced ReA may appear in the U.S. each year compared to about 125,000 new cases of rheumatoid arthritis. This is a low estimate since it does not include cases resulting from Chlamydia pneumoniae. “Thus, Chlamydia-induced ReA represents a considerable burden on the health care systems of the U.S. and other nations, and its impact on those systems may well be significantly underrecognized,” the authors state.

Most women with genital Chlamydia trachomatis infection have no symptoms at the time of the initial infection; this was also true of the patients in the study who had DNA evidence of Chlamydia. For Chlamydia pneumoniae, as many as 70 percent of acute infections are asymptomatic and, even when there are symptoms, definitive identification of the organism is rare. The authors point out that relying on identification of a symptomatic infection may therefore result in routine underdiagnosis or misdiagnosis of Chlamydia-induced ReA.

They add that because ReA is a type of SpA and patients with ReA do not present with the classic combination of symptoms of arthritis, conjunctivitis/iritis and urethritis, it is reasonable to believe that Chlamydia trachomatis plays a role in causing uSpA, which may in fact be ReA. They conclude that although there is no diagnostic test for Chlamydia-induced ReA, testing for chlamydial DNA in the synovial tissue of patients thought to have ReA may be the most accurate way of diagnosing the condition.

make a difference: sponsored opportunity

Story Source:

osteoarthritis rheumatoid arthritis and gouty arthritishow to osteoarthritis rheumatoid arthritis and gouty arthritis for Materials provided by Wiley-Blackwell. Note: Content may be edited for style and length.


Journal Reference:

  1. Carter et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis & Rheumatism, 2009; 60 (5): 1311 DOI: 10.1002/art.24431

osteoarthritis rheumatoid arthritis and gouty arthritishow to osteoarthritis rheumatoid arthritis and gouty arthritis for Cite This Page:

Wiley-Blackwell. "" ScienceDaily. ScienceDaily, 6 May 2009. <www.sciencedaily.com/releases/2009/04/090430161234.htm>.
Wiley-Blackwell. (2009, May 6). Chlamydia May Play Role In A Type Of Arthritis. ScienceDaily. Retrieved April 27, 2020 from www.sciencedaily.com/releases/2009/04/090430161234.htm
Wiley-Blackwell. "" ScienceDaily. www.sciencedaily.com/releases/2009/04/090430161234.htm (accessed April 27, 2020).